Literature DB >> 32789462

Use of Physician Global Assessment in systemic lupus erythematosus: a systematic review of its psychometric properties.

Elisabetta Chessa, Matteo Piga1, Alberto Floris1, Hervé Devilliers2, Alberto Cauli1, Laurent Arnaud3,4.   

Abstract

OBJECTIVE: The Physician Global Assessment (PGA) is a visual analogue score that reflects the clinician's judgement of overall SLE disease activity. The aim of this systematic literature review is to describe and analyse the psychometric properties of the PGA.
METHODS: This systematic literature review was conducted by two independent reviewers in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. All articles published through 1 July 2019 in PubMed were screened, with no limitation on year of publication, language or patients' age. Psychometric properties data were analysed according to the OMERACT Filter methodology version 2.1.
RESULTS: The literature search identified 91 studies. Face validity was reported in all the articles retrieved in which the PGA was used alone or as part of composite indices (Systemic Responder Index, Safety of Estrogen in Lupus Erythematosus National Assessment Flare Index, Lupus Low Disease Activity State, Definitions of Remission in Systemic Lupus Erythematosus criteria). Content validity was reported in 89 studies. Construct validity was demonstrated by a good correlation (r ≥ 0.50) between the PGA with the SLEDAI (12 studies), SLAM (4 studies), LAI, BILAG and ECLAM (2 studies each). Criterion validity was assessed exploring the PGA correlation with quality of life measurements, biomarker levels and treatment changes in 28 studies, while no study has evaluated correlation with damage. A good responsiveness for PGA was shown in eight studies. A high variability in scales was found, causing a wide range of reliability (intraclass correlation coefficient 0.67-0.98).
CONCLUSION: PGA is a valid, responsive and feasible instrument, though its reliability was impacted by the scale adopted, suggesting the major need for standardization of its scoring.
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  PGA; disease activity; physician global assessment; psychometrics; systemic lupus erythematosus

Mesh:

Year:  2020        PMID: 32789462     DOI: 10.1093/rheumatology/keaa383

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  7 in total

1.  Pilot Intervention to Improve Medication Adherence among Patients with Systemic Lupus Erythematosus Using Pharmacy Refill Data.

Authors:  Kai Sun; Amanda M Eudy; Jennifer L Rogers; Lisa G Criscione-Schreiber; Rebecca E Sadun; Jayanth Doss; Mithu Maheswaranathan; Ann Cameron Barr; Lena Eder; Amy L Corneli; Hayden B Bosworth; Megan E B Clowse
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-11-05       Impact factor: 5.178

2.  Improving patient pathways for systemic lupus erythematosus: a multistakeholder pathway optimisation study.

Authors:  Aurelien Schlencker; Laurent Messer; Marc Ardizzone; Gilles Blaison; Olivier Hinschberger; Etienne Dahan; Christelle Sordet; Julia Walther; Anne Dory; Maria Gonzalez; Stéphanie Kleinlogel; Aurélia Bramont-Nachman; Lionel Barrand; Isabelle Payen-Revol; Jean Sibilia; Thierry Martin; Laurent Arnaud
Journal:  Lupus Sci Med       Date:  2022-05

3.  Physician Global Assessment as a Disease Activity Measure for Relapsing Polychondritis.

Authors:  Emily Rose; Marcela A Ferrada; Kaitlin A Quinn; Wendy Goodspeed; Laurent Arnaud; Aman Sharma; Hajime Yoshifuji; Jeff Kim; Clint Allen; Arlene Sirajuddin; Marcus Chen; Peter C Grayson
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-04-29       Impact factor: 5.178

4.  'Not at target': prevalence and consequences of inadequate disease control in systemic lupus erythematosus-a multinational observational cohort study.

Authors:  Rangi Kandane-Rathnayake; Worawit Louthrenoo; Alberta Hoi; Shue-Fen Luo; Yeong-Jian J Wu; Yi-Hsing Chen; Jiacai Cho; Aisha Lateef; Laniyati Hamijoyo; Sandra V Navarra; Leonid Zamora; Sargunan Sockalingam; Yuan An; Zhanguo Li; Yasuhiro Katsumata; Masayoshi Harigai; Yanjie Hao; Zhuoli Zhang; Jun Kikuchi; Tsutomu Takeuchi; B M D B Basnayake; Madelynn Chan; Kristine Pek Ling Ng; Nicola Tugnet; Sunil Kumar; Shereen Oon; Fiona Goldblatt; Sean O'Neill; Kathryn A Gibson; Naoaki Ohkubo; Yoshiya Tanaka; Sang-Cheol Bae; Chak Sing Lau; Mandana Nikpour; Vera Golder; Eric F Morand
Journal:  Arthritis Res Ther       Date:  2022-03-14       Impact factor: 5.156

5.  Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosus.

Authors:  Philippe Mertz; Matteo Piga; Elisabetta Chessa; Zahir Amoura; Reinhard E Voll; Andreas Schwarting; Francois Maurier; Gilles Blaison; Bernard Bonnotte; Vincent Poindron; Christoph Fiehn; Hanns-Martin Lorenz; Anne-Sophie Korganow; Jean Sibilia; Thierry Martin; Laurent Arnaud
Journal:  RMD Open       Date:  2022-09

Review 6.  Diet and Systemic Lupus Erythematosus (SLE): From Supplementation to Intervention.

Authors:  Hanxiao Jiao; Gizem Acar; George A Robinson; Coziana Ciurtin; Elizabeth C Jury; Anastasia Z Kalea
Journal:  Int J Environ Res Public Health       Date:  2022-09-20       Impact factor: 4.614

Review 7.  Patient-Reported Outcomes in Systemic Lupus Erythematosus. Can Lupus Patients Take the Driver's Seat in Their Disease Monitoring?

Authors:  Ioannis Parodis; Paul Studenic
Journal:  J Clin Med       Date:  2022-01-11       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.